OliX Pharmaceuticals Inc (226950) Stock Price & News

Why is 226950 down 2.17%?

Dive Deeper

226950:KOSDAQ

OliX Pharmaceuticals Inc

₩85,500.00

-2.17%

(-1,900.00) 1D

Nov 4, 3:30:17 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 226950...

Open

₩88,900

High

₩89,000

Low

₩79,400

Mkt. cap

1.96T

Avg. vol.

218.72K

Volume

342.23K

52-wk high

₩217,000

52-wk low

₩79,400

EPS

-₩602

Shares outstanding

22.87M

No. of employees

Open

₩88,900

High

₩89,000

Low

₩79,400

Mkt. cap

1.96T

Avg. vol.

218.72K

Volume

342.23K

52-wk high

₩217,000

52-wk low

₩79,400

EPS

-₩602

Shares outstanding

22.87M

No. of employees

Related stocks

LigaChem Biosciences Inc

News stories

From web sources and news partners

FinancialContent

39 minutes ago

Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings

WTTW News

56 minutes ago

Dow Has Best Post-Midterm Elections Day in 44 Years as Democrats Take Control of Congress

MarketWatch

40 minutes ago

This year’s worst-performing S&P 500 stock is finally seeing some major relief

PBS

2 hours ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About OliX Pharmaceuticals Inc

CEODong Ki Lee

Employees81

Founded2010

Headquarters-

SectorBiotechnology

Industry-

Websiteolixpharma.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.91B	4.53B	3.57B	2.62B
Cost of goods sold	79.67M	99.38M	38.24M	115.54M
Cost of revenue	79.67M	99.38M	38.24M	115.54M
Research and development expenses	4.37B	8.67B	8.83B	9.68B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.27B	3.79B	5.01B	6.35B
Operating expense	11.14B	12.89B	14.32B	16.51B
Total operating expenses	11.22B	12.99B	14.36B	16.62B
Operating income	-8.31B	-8.46B	-10.79B	-14.00B
Other non operating income	-587.89M	23.70B	811.24M	2.68B
EBT including unusual items	-8.66B	15.52B	-9.77B	-10.99B
EBT excluding unusual items	-8.93B	15.53B	-9.75B	-11.01B
Income tax expense	-	128.02M	-	-
Effective tax rate	-	0.82%	-	-
Other operating expenses	189.23M	122.62M	215.69M	195.59M
Net income	-8.66B	15.39B	-9.77B	-10.99B
Net profit margin	-297.89%	339.73%	-273.50%	-418.65%
Earnings per share	-	-	-	-
Interest and investment income	246.89M	810.31M	687.62M	632.65M
Interest expense	-334.31M	-273.96M	-256.90M	-246.88M
Net interest expenses	-87.42M	536.35M	430.71M	385.77M
Depreciation and amortization charges	299.95M	297.06M	259.58M	267.34M
EBITDA	-7.71B	-7.86B	-10.22B	-13.42B
Gain or loss from assets sale	-280.73M	1.46M	-13.77M	19.20M

Finance

Ask anything